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Abstract
The purpose of this paper is to analyze whether or not investing more funds into research and development
will lead to higher profitability, and the analysis will be done by examining the musculoskeletal division of the
medical device industry. My research will tie in with production function theory as well as Schumpeter’s
theory of creative destruction. This paper will also use past research to show what has been done to evaluate
the positive relationship between research and development and risk and how this could alter profitability.
Through theory and past research an appropriate testable hypothesis will be developed. In order to test the
hypothesis, data will be drawn and used in regression analysis as well as descriptive statistics to verify a
significant relationship. In order to perform regression analysis an empirical model will be made which will
show the dependent variable and how it will be tested against an independent variable as well as control
variables. A discussion of the results will then occur as well as mention of future research.
This article is available in The Park Place Economist: http://digitalcommons.iwu.edu/parkplace/vol19/iss1/12
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An Analysis on Investment into 
Research and Development and Its 
Influence on Profitability in the Medical 
Device Sector of the Economy
Jake Nord
I. Introduction
“Fundamental to capitalistic growth is innovation.” This 
quote is from the survey article entitled “Contemporary 
Capitalism.”(Lazonick, 2008) Innovation is the process that 
generates goods and services that are of better quality and 
lower prices than their predecessors. Therefore, if a firm 
explores innovation, then they will inevitably lead themselves to 
an efficient allocation of society’s resources and growth within 
the firm will occur. Innovation does not only improve a firm’s 
profitability but also the quality of life for all consumers in the 
economy. There is no greater need for innovation than in the 
medical sector of the economy. With an aging population, and 
an estimated life expectancy of now 78, consumers in America 
are constantly demanding new hip prostheses, shoulder 
fracture components, and spinal implants. The need for 
innovation and the diverse investment strategies into research 
and development in the medical device sector of the economy 
should allow for the medical device sector to provide a good 
focus for this paper’s research analysis. 
The purpose of this paper is to analyze whether or not investing 
more funds into research and development will lead to higher 
profitability, and the analysis will be done by examining the 
musculoskeletal division of the medical device industry. My 
research will tie in with production function theory as well as 
Schumpeter’s theory of creative destruction. This paper will 
also use past research to show what has been done to evaluate 
the positive relationship between research and development 
and risk and how this could alter profitability. Through theory 
and past research an appropriate testable hypothesis will be 
developed. In order to test the hypothesis, data will be drawn 
and used in regression analysis as well as descriptive statistics 
to verify a significant relationship. In order to perform regression 
analysis an empirical model will be made which will show 
the dependent variable and how it will be tested against an 
independent variable as well as control variables. A discussion 
of the results will then occur as well as mention of future 
research. 
II. Theory
Theoretically, expenditure on research and development should 
have a significantly positive relationship with the profitability of 
the firm. As explained by Ikoma (2006), “Even if the production 
yield gradually decreases with more innovation, simplifying 
production processes can have a significant impact on profits.” 
Ikoma’s idea can be shown through past research. According 
to Kafouros (2005) a high investment into research and 
development should have a significantly positive relationship 
with productivity. A Cobb-Douglass production function as well 
as Schumpeterian theory also suggests a relationship between 
productivity and profitability. Finally, past research will show 
how risk in investing into research and development can affect 
a firm’s profitability. 
Past research has been done in the UK examining 170 
firms showing that an increase in research and development 
expenditure will increase the firm’s productivity, Kafouros 
(2005). The empirical findings show that there is a positive and 
significant impact that research and development expenditure 
has on productivity. There seems to be a higher rate of return 
on research and development expenditures for sectors that 
are the net users of innovation. In other words, for sectors of 
the economy that focus on innovation, their expenditure on 
research and development will have a more significant impact 
on their productivity. 
 
The research design used by Kafouros (2005) focused on the 
Cobb-Douglass production function in its growth rate form. 
The model contains the standard factors of capital and labor, 
but also includes the factor of knowledge capital. The purpose 
for including the factor of knowledge capital is to capture 
the increases in productivity that come from an increase in 
technology. 
All of the 170 firms were quoted on the UK stock market. The 
firms chosen for the research come from the manufacturing 
sector of the UK economy, and information on all firms 
were found, however some firms were reported as having 
no investment into research and development and were 
disregarded. Furthermore, the 170 firms are segregated 
into two groups; innovating and non-innovating for a deeper 
evaluation of the data. (Kafouros, 2005)
The paper uses what it calls “R&D intensity” which is the 
average of R&D expenditure over sales for the year as its main 
factor in determining profitability. The average R&D intensity 
for all of the UK manufacturing is 2.1%. In order to calculate 
productivity, data were collected on employment, capital and 
output for each firm. Employment was calculated as the firm’s 
number of employees, capital was measured using total fixed 
gross assets, and finally total sales were used to measure 
output. Sales and capital were both divided by employment in 
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order to get per capita values. (Kafouros 2005)
The regression analysis used in this article was ordinary least 
squares. The article runs three regressions. The dependent 
variable of each model is productivity growth. The first model 
included only the capital to labor ratio. The second added R&D 
intensity to the mix. Finally the labor term was added for the 
third regression in order to check for constant returns to scale. 
The same estimates are then repeated in the article with the 10 
sector dummy variables in order to check for a consistency over 
all sectors.
 
The results show that R&D intensity is significant at the .10 
level. The gross rate of return, accounting for constant returns 
to scale and labor, is .27. In other words, for every addition 
pound spent on research and development yielded output 
would increase by £1.27 holding all other things constant. The 
results found by Kafouros are similar to results found in Japan, 
the US, and France which were done in other similar research 
papers. When the sample is split, there is a higher return for 
innovating firms than non-innovating firms. This shows that 
being an innovator is an important factor when considering 
investment into research and development. However, once 
dummy variables were introduced the variable R&D intensity 
became insignificant. The dummy variables include time 
differences and industry differences. The results here show 
that there is an important role for different sector conditions 
in allowing for innovation and advancement in productivity. 
(Kafouros 2005)
Kafouros (2005) shows that there is a significant and positive 
correlation between research and development expenditure 
and productivity. The findings here are extremely crucial 
because if we can show that if the profitability of a firm rises 
along with productivity of a firm then theoretically research and 
development expenditure should have a significant and positive 
relationship with the profitability of the firm.  In order to show 
this relationship I will use Cobb-Douglass Production as well as 
Schumpeterian theory.
As shown by Howitt (2008), the Cobb-Douglass production 
function shows that advancement in technology leads to a 
higher growth in output.   The Cobb-Douglass production 
function is an extension of the typical production function that 
states that q = F (K,L). Here, the output of a firm is dependent 
on a function of capital and labor. The Cobb-Douglass 
production function takes this concept a little bit further and 
states F(K,L) = AKαLβ. The important thing to notice about this 
equation is the addition of the “A” variable. “A” is a constant 
which represents technology or productivity. According to the 
Cobb-Douglass production function “The larger the value of A, 
more can be produced for a given level of K and L. (Pindyke, 
2009)” By applying this to my research paper we can see 
that theoretically a larger investment into R&D should result 
in a greater change in “A”, which would cause the company 
to become more efficient in its production. Technological 
improvement is shown illustratively in Figure 1.  
Figure 1:
 
The Cobb-Douglass production function shows that if there is 
advancement in technology, then there will be output growth. 
The next step is to show the relationship between output growth 
and profitability growth. If there is an increase in the productivity 
of a firm, this means that the firm can generate more output 
for each input, and as shown in figure 1, the curve of the 
production function will rise. Therefore, there will be a fall in per 
unit cost for the firm and profits will rise. If this occurs then the 
firm may become more profitable. Not only could investment in 
R&D boost production, but it could also create new products. 
The new products could bring in new profits by themselves, 
thus leading to a growth in profitability. 
Along the lines of new products comes Schumpeterian theory.  
This theory was developed by Joseph Schumpeter in 1942. 
Schumpeter argues that “in dealing with capitalism we are 
dealing with an evolutionary process.” He goes on to state 
that the “main driving force of capitalism is the creation of new 
goods and new methods of production.( Heertje, 2008)” The 
theory centers around the idea that when innovation takes place 
new products are made that cause older products to become 
obsolete. He calls this process “creative destruction” because 
the creation of a new product destroys the market for an older 
product. Schumpeter argues that in order for firms to survive in 
an industry they must compete for creating new products. Firms 
do this by investing into research and development. In other 
words in order for an economy to grow faster the economy 
must invest more capital and resources into research and 
development. Schumpeter goes on to argue that the process 
of creative destruction takes time. Investment into research 
and development may not have an influence in the economy 
for a number of years. Interestingly Schumpeter argues that 
price competition is not the only component of market behavior. 
Rather, firms compete for producing new advanced products. 
Therefore, by investing more into research and development a 
firm has a higher probability of creating that new product, which 
will give them higher returns, and therefore higher profitability.  
As shown by past research done by Kaforous (2005) as well 
as the Cobb-Douglass production function and Schumpeterian 
theory, as a firm invests more funds into research and 
development the firm should experience higher profitability.
Theoretically it is true that as firms invest more into research 
and development they will experience higher profitability. 
However, investing into research and development is 
investing into an unforeseeable future. The risk is that there 
is a possibility of the new product not performing well, not 
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being desired, or not outperforming other products in the 
market. Therefore, as a firm invests more into research and 
development they are taking a gamble. The gamble will 
theoretically, on average, generate higher profits. However, 
gambling on R&D will also likely generate greater variability in 
profits compared to firms that do not take significant gambles 
on R&D. 
Machina and Rothschild (2008) state that, “The phenomenon 
of risk is one of the key determining factors in the formation of 
investment decisions.” Furthermore, the article states that there 
can be two types of investors in an economy, a risk adverse 
person and a risk lover. In relation to this paper, companies that 
invest little into research and development may be more risk 
adverse than those that invest more funds into research and 
development. The incentive for a risk loving investor should 
be that the possible gains of his investment should be more 
than the possible losses. Therefore, even with the possibility 
of the investment into research and development going sour, 
the possible gains should outweigh the possible losses. As 
firms invest more into research and development we should 
see a higher volatility of returns, however the overall correlation 
taking into account this volatility, should still be positive between 
investment into research and development and profitability.  
This leads me to state my formal hypotheses:
 
Hypothesis I
As more funds are spent on research and development a firm’s 
profitability will increase leading to a higher rate of return on the 
firm’s stock price.
Hypothesis II 
As more funds are spent on research and development a firm’s 
profitability will become more volatile causing a firm’s rate of 
return on their stock price to fluctuate more over time. 
III. Data and Empirical Model
The data for my empirical model will come from the 
musculoskeletal division of the medical device industry of the 
economy. The companies have been gathered from the Cowen 
and Company Publically Traded Medical Technology Company 
Database. The data gathered for each company come from 
Yahoo! Finance and MSN Money. It will be necessary to 
manipulate the data, and use variables to control for differences 
between the companies. There are 16 companies in the 
analysis. A list of these companies can be seen in appendix 1. 
This paper will use ordinary least squares (OLS) regression 
analysis as well as descriptive statistics to study the relationship 
between investment into research and development and 
profitability. 
The reason for using the musculoskeletal division of the medical 
device sector stems from past research done by Kafouros 
(2005). The article shows that the sectors of the economy that 
experience the greatest growth in productivity from research 
and development expenditure are those companies that are 
the net users of innovation. In order to derive the best possible 
results it is necessary to use an industry that focuses on 
innovation. Medicine is one of those industries. As Americans 
are living longer, the older generation is continuously looking 
for new orthopedic devices. The advancing demand causes 
healthcare to be a hub for technological advancement.  
In order to measure the profitability of each firm this paper uses 
each firms’ rate of return on their stock price over the recent 
recession, which started in December 2007 and ended in June 
2009.  Since many of the companies’ data do not date back 
to before the most recent economic expansion this analysis 
is restricted to only focusing on the most recent economic 
recession, with no expansionary period included.  The reason 
for using stock prices is that the stock price of a firm should 
reflect investor’s perception of the present value of future net 
earnings for that firm. 
In order to measure investment into research and development 
it is necessary to extrapolate the data from the financial sheets 
of each company. In order to control for the differing sizes in 
each company, investment into research and development 
is taken as a percentage of revenue. Since research and 
development expenditures usually do not affect the market for 
1.5 to 3 years it will be necessary to view the investment into 
research and development from 2005 to 2007. Other controls 
are necessary for the OLS regression. A summary of all of the 
variables for this paper’s analysis is listed in Table 1. 
Equation for my analysis: Rate of return = β1 + β2(R&D/
Revenue)  + β3(Growth)  + β4(Free Cash Flow)  + β5(Market 
Share)   + β6(Size) + β7(External Financial Dependence)  +  e
The control variables seen in the table come from (Salamanca 
2010). In his article he describes how a number of variables 
could affect a firm’s decision on how much to invest into 
research and development. His analysis will give the correct set 
of tools to control for various factors that could affect investment 
into research and development. 
Firm growth should have a positive relationship with profitability. 
R&D spending facilitates the success of the firm in the product 
market, and as a result, R&D spending leads to a higher rate of 
growth. Therefore, if a firm has been successful in the market in 
previous years, then they will most likely have better success in 
their research and development expenditures in the future. This 
is needed to control for in explaining why some firms may invest 
more into research and development than others. 
Free cash flow is a measurement of all of the available funds 
in excess of funds needed to pay for all NPV projects. This 
statistic is taken off of each company’s financial statements.  
According to the article free cash flow should have a negative 
impact on a firm’s profitability because a firm with excess funds 
may be persuaded to invest into riskier endeavors. 
Market share is the percentage of sales a firm has of the 
total sales in their market. For this dataset each company’s 
revenues are added up and that is the market base. The market 
share for each company is calculated as the percentage of 
each company’s revenue of the market base. According to the 
article market share should have a positive relationship with 
profitability. A firm with higher market share will tend to innovate 
more, leading to more profitability. Also a company with a 
higher market share may be more widely known and have their 
products tested by the public more often than other firm’s due to 
reputation. 
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The size of a firm is a measurement of how many employees 
the firm has. According to the article the size of a firm is 
positively related to firm profitability. A larger firm can take 
advantage of economies of scale as well as easier access to 
capital markets and R&D cost spreading. 
External financial dependence captures the proportion of 
a firm’s investments that cannot be financed by internal 
resources. According to the article external financial 
dependence is a “handicap” that is negatively assessed by 
the market when firms undertake R&D projects. What the 
article means by a “handicap” is that the firm may not be able 
to explore all possible R&D projects because they are being 
funded by outside sources. Therefore, firms with more external 
financial dependence may be at a disadvantage. 
Labor and capital intensity deal with the amount of labor 
and capital used in the research and development process. 
Since financial statements do not reveal this information it is 
impossible to retrieve these statistics. 
All of these control statistics, with the exception of firm growth, 
will be measured from 2005-2007 in order to stay in line with 
the investment into research and development statistics. Firm 
growth will be measured from 2004-2006 in order to account for 
the growth of the firm in the year prior to the decision to invest 
into research and development (Salamanca 2010).
IV. Results
The regression results for four models are presented in Table 
2. The first model includes only the primary independent 
variable, R&D / Revenue. Model two includes in the financial 
controls which are firm growth, free cash flow, and external 
financial dependence. The third regression includes all 
variables. The fourth and final regression is a correction for 
heteroscedasticity. 
As shown in Table 2, there is not a lot of significance in 
these regressions, which does not give much support 
for the first hypothesis, which claims a direct relationship 
between R&D expenditures and the changes in stock price. 
However, a White’s test was ran which showed that there 
was heteroscedasticity, which gives some support for the 
second hypothesis. Heteroscedasticity explains that as the 
independent variable changes, the standard deviation of the 
dependent variable will change as well. In relation to this 
paper, heteroscedasticity is showing that as investment into 
R&D grows, the standard deviation of the rate of return of 
stock prices is growing as well, which is showing that there 
is a sense of risk in investing more funds into research and 
development. In other words, heteroscedasticity is explaining 
that by investing more into research and development the data 
are experiencing more volatile returns in their stock price. By 
using descriptive statistics more evidence can be shown for the 
second hypothesis.   
The scatter plot in Figure 2 shows all of the data with relation 
to their investment into R&D and their rate of return on their 
stock price over the recession period. In order to perform a 
descriptive statistical analysis the data will be split into two. 
The division of the data is shown in the scatter plot by a vertical 
line. The descriptive statistics will analyze the two hypotheses 
by evaluating the statistical differences in means of the rate of 
returns for the two groups as well as evaluating the statistical 
difference in each groups’ standard deviation of their rate of 
return.
In order to perform descriptive statistics the data were split into 
two groups, which are a low investment into R&D group and 
a high investment into R&D group. Figure two illustrates the 
division of data through a scatter plot. Here you can visually see 
evidence for heteroscedasticity in the data. 
FIgure 2:
Table 3 shows the firms who have a smaller investment into 
research and development listed on the left in blue, and the 
firms who have invested more into research and development 
listed on the right. The key figures to focus on here are the 
mean and standard deviation of the two groups. As expected, 
the mean rate of return on stock price for the higher invested 
into R&D firms is higher than the lower invested R&D firms, 
which shows evidence for the first hypothesis. Also, the 
standard deviation is higher for the higher invested R&D firms 
than the lower invested R&D firms, which shows evidence for 
the second hypothesis. By using descriptive analysis, this paper 
will test if the means and standard deviations for the two groups 
are statistically different.
The two sample test of means with σ unknown and unequal 
failed to reject the null hypothesis; therefore we cannot say 
that the means for the two groups is statistically different in 
this analysis. Therefore, due to the regression analysis and 
the descriptive statistics failing to show support for the first 
hypothesis we must reject it, and we cannot say that as firms 
invest more funds into research and development they will 
experience a higher rate of return on their stock price. These 
results do not coincide with this paper’s theory which was 
developed through past research done in Kafouros (2005). The 
theory was that as production improved so would profitability. 
These results are troublesome. However, with future research 
and adjustments to this analysis, hopefully future results will be 
more significant. The results for the two sample test of means 
with σ unknown and unequal are shown in Table 4.
The difference in standard deviations test rejected the null 
hypothesis. Therefore, we can say that there is a significant 
difference in standard deviations for this analysis, and we can 
accept hypothesis 2, which states that as more funds are spent 
on research and development a firm’s profitability will become 
more volatile causing a firm’s rate of return on their stock price 
to fluctuate more over time. These results do coincide with 
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theory stated in Machina (2008). Risk, therefore, does play its 
role in expenditure on research and development. The analysis 
for a difference in standard deviations can be shown in Table 5.
More analysis was done on these two groups to understand 
why some companies spend more on research and 
development and others spent less. This paper analyzed 
the differences in the two groups by looking at their control 
variables, which included firm size, firm growth, free cash flow, 
market share and external financial dependence. Another 
variable was included in this analysis, which was the beta 
coefficient. The beta coefficient is a measure of a firm’s stock 
price volatility. 
As shown the firms who spent more on research and 
development typically have fewer employees, a higher growth 
rate, less free cash flow, a lower market share, and less 
external financial dependence. In other words, those who 
spend more on research and development tend to be smaller 
and more growth driven. Those who spent less on research 
and development tend to be more well established and more 
risk adverse. Those larger, more risk adverse firms who spend 
less on research and development also tend to have a more 
stable stock price, which is supported by the beta coefficient. 
This conclusion is also supported by the results found in the 
regression analysis as well as the descriptive statistics for the 
difference in the standard deviation for each group. 
V. Conclusion
This paper has shown that as research and development 
increases for a firm, their rate of return on their stock price 
does not necessary increase more relative to other firms. 
However, this paper has shown that those who spend more on 
research and development do experience more volatile returns. 
Therefore, the first hypothesis is rejected and the second 
hypothesis is not rejected in the context of this paper. In relation 
to other findings, Kafouros’s (2005) findings that a higher 
investment into research and development will generate greater 
productivity is neither supported nor rejected by the findings 
presented here due to the differences in foci in the two papers. 
The focus of Kafouros (2005) was productivity, and the focus 
in this paper was profitability. Schumpeterian theory and the 
Cobb-Douglass production are neither supported nor rejected 
for the same purposes. However, Machine and Rothschild 
(2008) are supported by the findings of this paper, which show 
that more investment into research and development lead to a 
greater deal of risk.
In order to improve the analysis, future research could evaluate 
the problem addressed in this paper differently. Future 
research could involve a larger database, a different sector 
of the economy, or even use a different time period. By using 
a larger database outliers’ effect on the database could be 
weakened. Also with more data the strength of the regression 
analysis would grow. In order to get a larger database future 
research could either analyze a different sector of the economy, 
or it could include more data in this sector of the economy. 
For example, the data in this database came strictly from the 
musculoskeletal medical device sector; however the database 
could expand itself to include other medical device makers 
outside of the musculoskeletal sector. Finally, future research 
could examine a difference time period. Seeing that the time 
period used was during a recession, there could have been 
more extreme volatility than we would typically expect. Also 
during a recession most companies are acquiring negative 
returns and the firms are doing damage control. However, it 
would be interesting to see an analysis of an expansionary 
period where innovation is encouraged more. 
So, what do the results mean? Should companies spend more 
or less on research and development? The paper has given 
us the answer that it depends. If a company is smaller and 
more growth oriented, it could be beneficial to take the risk for 
higher returns, however if a company is more well established 
and is in a good position with more market share, it could be 
more beneficial to spend less of their revenue on research and 
development. 
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Variable Definition Expected sign 
Dependent Variable:   
Profitability Change in stock price over the recession  
(Dec, 1 2007 – Jun, 1 2009) 
 
Explanatory variables:   
Main Focus   
R&D / Revenue Amount in dollars spent in R&D / Revenue + 
Control Variables   
Growth Change in revenue over the time period 2004-2006  + 
Free Cash Flow Leveraged free cash flow as stated in financial 
statements 
- 
Market Share Revenue of individual firm over total  + 
Size Number of Employees  + 
External Financial Dependence External financials as stated in financial statements - 
Labor Intensity  Labor used in research and development - 
Capital Intensity Capital used in research and development - 
	  
                                  Table 2: R&D regression for Medical device Firms  
Variables Model 1 Model 2 Model 3 Model 4 
Constant -.474** 
(-4.198) 
-.489** 
(-3.225) 
-.382 
(-1.501) 
-.578** 
(-3.981) 
R&D / Revenue 1.360 
(1.110) 
1.452 
(.772) 
.502 
(.191) 
3.146 
(1.303) 
Firm Growth - -3.17E-5 
(-.016) 
.001 
(.323) 
-.001 
(-.479) 
Free Cash Flow - -9.37E-12 
(-.053) 
2.43E-10 
(.230) 
9.407E-11 
(.000) 
EFD - -1.47E-10 
(.284) 
-1.92E-10 
(-.207) 
3.570E-10 
(.000) 
Market Share - - .021 
(.313) 
-.010 
(-.234) 
Firm Size - - -6.37E-5 
(-.597) 
9.625E-6 
(.167) 
R^2 .015 -.244 -.460 -.210 
N 16 16 16 16 
	  
Table 1: Variable Definitions and Expected Signs
Reject Null Hypothesis if t-stat > 1.753 (.05) 
Sig level at .05* .01**
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 Firm size Firm growth Free cash flow Market share 
External financial 
dependence 
 
Beta Coefficient 
Low average  6,353 25% $441,000,000 12% $112,000,000 
 
.98 
High average  743 40% $4,710,000 0.90% $31,890,000 
 
1.09 
	  
Low R&D 
expenditure 
Investment into 
R&D 
Rate of Return High R&D 
expenditure 
Investment into 
R&D 
Rate of Return 
SNN 4.4% -34% ANIK 14.53 -65% 
SYK 6.25% -45% EXAC 6.36 -14% 
ZMH 5.12% -29% NUVA 20.67 -11% 
IART 5.48% -36% OFIX 8.00 -55% 
RTIX 2.14% -54% VITA 15.82 8% 
OSTE 5.23% -51% WMGI 7.30 -41% 
CNMD 4.42% -33% ARTC 9.82 -80% 
KCI 2.81% -53% SYNO 6.84 4% 
Mean 4.48 -42% Mean 11.17 -32% 
σ 1.38 10 σ 5.23 33 
	  
H0 : μROR1 = μROR2 
Ha : μROR1 ≠ μROR2 
tc = (Ẋ1 - Ẋ2) / (Sx1 – x2) 
Degrees of freedom = 8.27 
Reject if t > 1.86 
tc = .82  
We do not reject the null hypothesis 
	  
H0 : σROR1 = σROR2  
Ha : σROR1 ≠ σROR2 
Fc = S21 / S22 
Degrees of Freedom = 7,7 
Reject H0 if Fc > 3.787 
Fc = 10.82 
We reject the null hypothesis  
	  
Table 3: Two Group Data Set with Mean and Standard Deviation Analysis
Table 6: Analysis of Low R&D Expenditure Group and High R&D Expenditure Group
Table 5: Difference in Standard Deviations
Table 4: Two Sample Test of Means -  
Population Unknown and Unequal
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